期刊文献+

血清—腹水白蛋白梯度与食管静脉曲张破裂出血的关系 被引量:1

Relationship between Serum Ascites Albumin Gradient and Esophageal Variceal Bleeding
原文传递
导出
摘要 目的探讨血清—腹水白蛋白梯度(SAAG)在门脉高压性食管静脉曲张(esophageal varices,EV)破裂出血预测中的价值。方法测定57例肝硬化腹水患者SAAG值并行胃镜检查,以了解有无食管静脉曲张,以11g/L为界将57例患者分为高SAAG组及低SAAG组,采用χ2检验和Pearson相关分析法分析SAAG与食管静脉曲张之间的关系,并对食管静脉曲张伴出血和不伴出血者2组的SAAG值进行比较。结果57例患者中,并发食管静脉曲张破裂出血16例,非出血者41例,肝硬化并发食管静脉曲张破裂出血组的SAAG为(24.20±7.19)g/L,高于非出血组的(18.25±6.03)g/L,2组比较,差异有统计学意义(P<0.05)。结论SAAG与门脉压力密切相关,对预测门脉高压性食管静脉破裂出血有重要的临床价值。 [ Objective ] To explore the value of serum ascites albumin gradient ( SAAG ] in prediction of esophageal varices ( EV ] hemorrhage. [ Methods ] 57 patients with cirrhotic ascites were measured SAAG and examined with endoscopy to identify whether EV happened. The patients were divided into high SAAG group and low SAAG group by the value of 11 g/L. The relationship between SAAG and EV was analyzed by χ^2 test and Pearson correlation analysis. And the comparison was conducted between the SAAG value of EV with hemorrhage and that of non-hemorrhage. [ Results ] Of 57 patients, 16 had esophageal variceal bleeding, and 41 had no esophageal varieeal bleeding. SAAG of group with esophageal varieeal bleeding( 24.20 ± 7.19) g/h was higher than that of group with no esophageal variceal bleeding( 18.25 ± 6.03 ) g/L. The difference was significant between two groups( P 〈 0.05). [ Conclusion ] The level of SAAG is closely related with the portal venous pressure and has significant clinical value in prediction of esophageal vaiceal bleeding.
出处 《职业与健康》 CAS 2009年第10期1111-1112,共2页 Occupation and Health
关键词 血清-腹水白蛋白梯度 肝硬化 门脉高压 食管静脉曲张 破裂出血 Serum ascites albumin gradient Cirrhosis Portal hypertension Esophageal variceal bleeding
  • 相关文献

参考文献9

二级参考文献18

共引文献133

同被引文献25

  • 1王友春,马建党,范银忠.血清-腹水白蛋白梯度与食管静脉曲张关系的临床研究[J].临床肝胆病杂志,2006,22(1):45-46. 被引量:7
  • 2张莉,张澍田,于中麟,王伟,徐宝宏,张福奎.血清-腹水白蛋白梯度与食管-胃底静脉曲张破裂出血的关系[J].临床内科杂志,2007,24(2):92-93. 被引量:12
  • 3D'AMICO G, de FRANCHIS R. Upper digestive bleeding in cirrhosis. Post -therapeutic outcome and prognostic indica- tors[J]. Hepatology, 2003, 38(3},- 599-612.
  • 4GARCIA -TSAO G, SANYAL A J, GRACE ND, et al. Preven- tion and management of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J ]. Hepatology, 2007, 46 (3} 922 -938.
  • 5von ELM E, ALTMAN DG, EGGER M, et al. Strengthening the reporting of observational studies in epidemiology (StroBE} statement, guidelines for reporting observational studies[ J ]. BMJ, 2007, 335 ( 7624 ) 806 -808.
  • 6WALLACE BC, SCHMID CH, LAU J, et al. Meta -Analyst. software for meta -analysis of binary, continuous and diag-nostic data[J]. BMC Med Res Methodol, 2009, 9(1 ) : 80.
  • 7HOEFS JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease[J]. J Lab Clin Med, 1983, 102 (2) ; 260 -273.
  • 8PA-FFERSQN SW, STARLING EH. Qn the mechanical factors which determine the output of the ventricles[ J ]. J Physiol, 1914, 48= 357 -379.
  • 9RUNYON BA. Management of adult patients with ascites due to cirrhosis= an update [J]. Hepatology, 2009, 49(6)= 2087 - 2107.
  • 10GROSZMANN R J, GARCIA -TSAO G, BOSCH J, et al. Be- ta- blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N EnglJ Med, 2005, 353(21): 2254- 2261.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部